Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta G Marangoni

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nature Reviews. Rheumatology|January 13, 2017
Systemic sclerosis in 2016: Dermal white adipose tissue implicated in SSc pathogenesisJohn Varga, Roberta G Marangoni
Current Opinion in Rheumatology|August 12, 2017
The roles of dermal white adipose tissue loss in scleroderma skin fibrosisRoberta G Marangoni, Theresa T Lu
Spine|March 16, 2010
Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapyRoberta G Marangoni, Ari S R Halpern
Current Opinion in Rheumatology|August 18, 2016
Animal models of scleroderma: recent progressRoberta G Marangoni, John Varga, Warren G Tourtellotte
Revista Do Instituto De Medicina Tropical De Sao Paulo|May 29, 2012
Amplification of the flgE gene provides evidence for the existence of a Brazilian borreliosisElenice Mantovani, Roberta G Marangoni, Giancarla Gauditano, et al.
Clinical and Experimental Rheumatology|September 6, 2018
The novel adipokine C1q-TNF related protein 9 (CTRP9) is elevated in systemic sclerosis-associated interstitial lung diseaseBenjamin Korman, Rafael Alejo, Deepshika Sudhakar, et al.
Oncotarget|March 15, 2018
The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic targetJun Wei, Roberta G Marangoni, Feng Fang, et al.
JCI Insight|September 6, 2022
Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in sclerodermaRoberta G Marangoni, Poulami Datta, Ananta Paine, et al.
Arthritis Research & Therapy|October 25, 2012
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapyFeng Fang, Lei Liu, Yang Yang, et al.
Rheumatology International|January 14, 2016
Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohortLuiza F Rocha, Ana Paula Luppino Assad, Roberta G Marangoni, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nature Reviews. Rheumatology|January 13, 2017
Systemic sclerosis in 2016: Dermal white adipose tissue implicated in SSc pathogenesisJohn Varga, Roberta G Marangoni
Current Opinion in Rheumatology|August 12, 2017
The roles of dermal white adipose tissue loss in scleroderma skin fibrosisRoberta G Marangoni, Theresa T Lu
Spine|March 16, 2010
Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapyRoberta G Marangoni, Ari S R Halpern
Current Opinion in Rheumatology|August 18, 2016
Animal models of scleroderma: recent progressRoberta G Marangoni, John Varga, Warren G Tourtellotte
Revista Do Instituto De Medicina Tropical De Sao Paulo|May 29, 2012
Amplification of the flgE gene provides evidence for the existence of a Brazilian borreliosisElenice Mantovani, Roberta G Marangoni, Giancarla Gauditano, et al.
Clinical and Experimental Rheumatology|September 6, 2018
The novel adipokine C1q-TNF related protein 9 (CTRP9) is elevated in systemic sclerosis-associated interstitial lung diseaseBenjamin Korman, Rafael Alejo, Deepshika Sudhakar, et al.
Oncotarget|March 15, 2018
The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic targetJun Wei, Roberta G Marangoni, Feng Fang, et al.
JCI Insight|September 6, 2022
Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in sclerodermaRoberta G Marangoni, Poulami Datta, Ananta Paine, et al.
Arthritis Research & Therapy|October 25, 2012
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapyFeng Fang, Lei Liu, Yang Yang, et al.
Rheumatology International|January 14, 2016
Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohortLuiza F Rocha, Ana Paula Luppino Assad, Roberta G Marangoni, et al.
Pageof 2